Integragen Stock Retained Earnings
| ALINT Stock | EUR 0.45 0.01 2.27% |
Integragen fundamentals help investors to digest information that contributes to Integragen's financial success or failures. It also enables traders to predict the movement of Integragen Stock. The fundamental analysis module provides a way to measure Integragen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Integragen stock.
Integragen |
Integragen Company Retained Earnings Analysis
Integragen's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Integragen Retained Earnings | (39 M) |
Most of Integragen's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Integragen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Integragen has a Retained Earnings of (39 Million). This is 104.19% lower than that of the Biotechnology sector and 140.25% lower than that of the Health Care industry. The retained earnings for all France stocks is 100.42% higher than that of the company.
Integragen Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Integragen's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Integragen could also be used in its relative valuation, which is a method of valuing Integragen by comparing valuation metrics of similar companies.Integragen is currently under evaluation in retained earnings category among its peers.
Integragen Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0149 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 5.39 M | |||
| Shares Outstanding | 6.6 M | |||
| Shares Owned By Insiders | 65.89 % | |||
| Price To Earning | 44.59 X | |||
| Price To Book | 3.91 X | |||
| Price To Sales | 0.63 X | |||
| Revenue | 11.32 M | |||
| Gross Profit | 11.32 M | |||
| EBITDA | 20.18 K | |||
| Net Income | 15 K | |||
| Cash And Equivalents | 1.84 M | |||
| Cash Per Share | 0.77 X | |||
| Total Debt | 1.95 M | |||
| Debt To Equity | 0.93 % | |||
| Current Ratio | 1.71 X | |||
| Book Value Per Share | 0.31 X | |||
| Cash Flow From Operations | (2.49 M) | |||
| Earnings Per Share | 0.04 X | |||
| Target Price | 3.9 | |||
| Number Of Employees | 52 | |||
| Beta | 0.37 | |||
| Market Capitalization | 8.52 M | |||
| Total Asset | 9.6 M | |||
| Retained Earnings | (39 M) | |||
| Working Capital | 2 M | |||
| Current Asset | 6 M | |||
| Current Liabilities | 4 M | |||
| Z Score | -2.2 | |||
| Net Asset | 9.6 M |
About Integragen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Integragen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integragen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integragen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integragen Stock Analysis
When running Integragen's price analysis, check to measure Integragen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integragen is operating at the current time. Most of Integragen's value examination focuses on studying past and present price action to predict the probability of Integragen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integragen's price. Additionally, you may evaluate how the addition of Integragen to your portfolios can decrease your overall portfolio volatility.